케이피엠테크
#케이피엠테크(033270)
[단독/FDA일정] 코로나치료제
임상3상최총데이타발표
FDA긴급사용신청일정
Presentation viewable starting on Friday, March 5, 2021
Management will discuss its Phase 3 clinical trial of lenzilumab in patients hospitalized with COVID-19 including the timeline for the topline data release and the submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration, provide an update on the commercial preparation ahead of a potential EUA for lenzilumab and an overview of the Company’s other development programs.
https://ir.humanigen.com/news/news-details/2021/Humanigen-to-Present-at-Multiple-Investor-Conferences-in-March/default.aspx
전문가방송
연관검색종목 03.28 23:30 기준
0/1000 byte